Sort
15,842 grants matching “pancreatic cancer”
Defining the role of the mitochondrial protein, GOT2, in pancreatic cancer metastasis and epigenetic dysregulation
$53,974Luis Francisco Diaz · Oregon Health & Science University · F31 · FY2024 · CA
Hyperspectral Microendscopy to Monitor VEGF During Pancreatic Cancer Therapy
$53,942Bryan Quilty Spring · Massachusetts General Hospital · F32 · FY2012 · CA
Deciphering the Role of eIF5A/PEAK1 Pathway in Pancreatic Cancer
$53,942Ken Fujimura · University Of California, San Diego · F32 · FY2013 · CA
Preclinical Translational Cancer Research Program
$53,817Min Li · University Of Oklahoma Hlth Sciences Ctr · P30 · FY2022 · CA
Preclinical Translational Cancer Research Program
$53,817Min Li · University Of Oklahoma Hlth Sciences Ctr · P30 · FY2021 · CA
Preclinical Translational Cancer Research Program
$53,817Min Li · University Of Oklahoma Hlth Sciences Ctr · P30 · FY2018 · CA
Preclinical Translational Cancer Research Program
$53,817Min Li · University Of Oklahoma Hlth Sciences Ctr · P30 · FY2020 · CA
Mechanistic regulation of tumor specific forms of cyclin E in breast cancer
$53,810Nikki A Delk · Rice University · F32 · FY2010 · CA
Integrating roles of noncoding RNPs in RNA biogenesis, RNA decay and cell survival
$53,786Christian Tschudi · Yale University · R01 · FY2017 · GM
Identification of mechanisms of diabetes predisposition in the 9p21 locus
$53,714Jason Boke Wright · Broad Institute, Inc. · F32 · FY2012 · DK
Musashi-mediated control of pancreatic cancer growth and progression
$53,663Tannishtha Reya · University Of California, San Diego · R01 · FY2017 · CA
The Ohio State University Pancreatic Disorders Network (OSU-PDN)
$53,541Darwin Lewis Conwell · Ohio State University · U01 · FY2019 · DK
Histone chaperones and cell state regulation
$53,484Amanda Rietta Wasylishen · University Of Cincinnati · R01 · FY2024 · DK
Surgical Studies of Pancreatic Stem Cells
$53,471Steven D Leach · Johns Hopkins University · R01 · FY2007 · DK
CANCER ASSOCIATED FIBROBLAST CLONALITY, CHROMATIN ACCESSIBILITY AND THERAPEUTIC TARGETING IN PANCREATIC DUCTAL ADENOCARCINOMA STROMA
$53,403Deshka Stonorov Foster · Stanford University · F32 · FY2020 · CA
Harnessing hotspot specific differences among SF3B1 mutations to define novel mechanisms of tumorigenicity and targetability in solid malignancies
$53,373Riley Bergman · Vanderbilt University · F30 · FY2024 · CA
Cancer-associated fibroblasts promote thyroid cancer malignancy through Wnt signaling
$53,373Matthew A Loberg · Vanderbilt University · F30 · FY2024 · CA
Defining the Contributions of Pancreatic Ductal and Acinar Cells to Tumorigenesis
$53,354Sam C. Wang · University Of California, San Francisco · F32 · FY2009 · CA
GASTRIN AND GROWTH AND DEVELOPMENT
$53,286Massachusetts General Hospital · K08 · FY2000 · DK
Targeting Chronic Lymphocytic Leukemia with DNA Nanoparticles
$53,282Laura E Ruff · University Of California, San Diego · F32 · FY2014 · CA
Investigating YAP's role during pathogenesis of pancreatic ductal adenocarcinoma
$53,282Binnaz Kucuk Staley · University Of California, San Francisco · F32 · FY2014 · CA
ATF5 in the developing pancreas and survival functions in the mature beta cell.
$53,282Christine Juliana · University Of Pennsylvania · F32 · FY2014 · DK
Two Phase Approach to Pancreatic Islet Transplantation
$53,282Bhupinder Singh Shergill · University Of California-Irvine · F32 · FY2014 · DK
Project 2: Endoscopic Photodynamic and Combination Therapy for Local and Metastatic Pancreatic Tumors
$53,170Stephen Pereira · Massachusetts General Hospital · P01 · FY2019 · CA
Examination of ceramide signaling in the crosstalk between pancreatic cancer cells and the tumor microenvironment
$53,150Audrey Marie Hendley · University Of California, San Francisco · F32 · FY2019 · CA